Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report. (2024). Dermatology Practical & Conceptual, 14(4), e2024252. https://doi.org/10.5826/dpc.1404a252